Learn About The Flagship VentureLabs Fellows Program

When: Tuesday, February 16th, 5:30pm-7pm

Where: TMEC 250

Dinner will be provided.

 

We are looking for outstanding scientists, engineers, inventors, and budding entrepreneurs to work hand-in-hand with our seasoned professionals through our unique entrepreneurial Exploration process, with the potential to ultimately produce exciting new ventures. 

The Flagship VentureLabs Fellows program provides an exclusive opportunity for graduating students to gain hands-on experience in Flagship VentureLabs’ approach to company conception, innovation and entrepreneuring. Fellows will work with VentureLabs Partners and Associates on Explorations focused on significant market opportunities, involving the formulation and testing of venture hypotheses around new technological platforms. Each Exploration will have the potential to advance from Exploration to ProtoCompany to a Flagship Ventures backed company.

Details

                 Fellowship runs in two cohorts, each over a 12 week period

                 Cohort 1:  June 6, 2016 – August 26, 2016

                 Cohort 2:  September 12, 2016 – December 2, 2016

                 Fellows will receive a stipend

                 Program takes place at the Flagship VentureLabs offices in Kendall Square, 1 Memorial Dr., 7th floor, Cambridge, Massachusetts 02142

About Flagship VentureLabs

Flagship VentureLabs® is the innovation foundry of Flagship Ventures. VentureLabs has been creating breakthrough companies since 2000. It is the first institution dedicated to entrepreneurial innovation, where the acts of discovery, invention and entrepreneuring are performed simultaneously by a world-class team of scientists, innovators and professional entrepreneurs. VentureLabs innovates, invents, launches and builds startups through a unique, systematic approach that produces best-in-class companies. VentureLabs has started over 35 life science and technology companies, including Moderna Therapeutics, Seres Therapeutics, Pronutria Biosciences, Symbiota and Joule Unlimited.